Throughout the last three months, 9 analysts have evaluated Capricor Therapeutics (NASDAQ:CAPR), offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 4 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 4 | 4 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.44, a high estimate of $43.00, and a low estimate of $8.00. This upward trend is apparent, with the current average reflecting a 21.4% increase from the previous average price target of $21.78.
Understanding Analyst Ratings: A Comprehensive Breakdown
The analysis of recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in
